Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
about
Characterization of novel Omp31 antigenic epitopes of Brucella melitensis by monoclonal antibodiesHighly optimized DNA vaccine targeting human telomerase reverse transcriptase stimulates potent antitumor immunity.Active evasion of CTL mediated killing and low quality responding CD8+ T cells contribute to persistence of brucellosis.Immunoproteomic identification of immunodominant antigens independent of the time of infection in Brucella abortus 2308-challenged cattleProtective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.Antigen-specific acquired immunity in human brucellosis: implications for diagnosis, prognosis, and vaccine development.MicroRNA Expression Patterns of CD8+ T Cells in Acute and Chronic Brucellosis.CD8+ T cell exhaustion, suppressed gamma interferon production, and delayed memory response induced by chronic Brucella melitensis infection.Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liverHydrodynamic immunization leads to poor CD8 T-cell expansion, low frequency of memory CTLs and ineffective antiviral protectionCD8 knockout mice are protected from challenge by vaccination with WR201, a live attenuated mutant of Brucella melitensis.Brucella melitensis T cell epitope recognition in humans with brucellosis in Peru.Immune reactivity of sera obtained from brucellosis patients and vaccinated-rabbits to a fusion protein from Brucella melitensis.Host susceptibility to Brucella abortus infection is more pronounced in IFN-γ knockout than IL-12/β2-microglobulin double-deficient mice.Antigen specific killing assay using CFSE labeled target cells
P2860
Q33691610-A360BF7D-37A2-4CAB-9A82-B411518B7AACQ33897405-B09E32E6-05CE-4EC2-A2CD-3C9960801CD1Q34256236-C949DB63-1E7A-4FED-9F59-EF36009A547AQ35132931-A32E56C3-1B5D-4E82-ACD7-BCA8CF2C9E62Q35273029-63A02F5D-CB1B-4605-BE5B-A9EA2C5F97E3Q36159276-AE69F2C0-CD1F-47F0-9EDB-3A6BAA5CB5D8Q36185548-62B1DD49-45A9-4F7F-817C-4AD46C5DC669Q36281282-7C24CB4B-B3AB-494A-8CC7-5531CDD64FFEQ36871557-77E5D5A3-BE7F-4E11-8A80-6B421996EE34Q37250507-0435BFA8-E34C-4026-90CA-4F95DF545BFAQ37316341-F1B8C9A6-4506-4BCE-AF96-9B0ECF2E4972Q37548090-A5FA1BE4-3B8B-4D31-8EBB-851C8C6D352CQ39001829-9B3913E6-A070-4A78-AB5B-481E1E291F66Q39802365-5955060D-F591-41A7-BBE0-86010BFF0E4FQ42146210-C7356D60-9813-4CDF-9236-00B74A032E0F
P2860
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
@ast
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
@en
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
@nl
type
label
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
@ast
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
@en
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
@nl
prefLabel
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
@ast
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
@en
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
@nl
P2093
P2860
P356
P1476
Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.
@en
P2093
Gary A Splitter
Jerome Harms
Linda Eskra
Marina A Durward
P2860
P304
P356
10.1128/IAI.00994-09
P407
P577
2009-11-02T00:00:00Z